We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+9.07%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.62B
AUM Growth
+$444M
Cap. Flow
+$302M
Cap. Flow %
11.51%
Top 10 Hldgs %
20.15%
Holding
3,121
New
53
Increased
339
Reduced
871
Closed
28

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$73.1M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$66.6M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$41.2M
4
BND icon
Vanguard Total Bond Market
BND
+$36.7M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$32.4M

Top Sells

Rank Stock Value
1
ENPH icon
Enphase Energy
ENPH
+$5.93M
2
GNRC icon
Generac Holdings
GNRC
+$4.86M
3
TRMB icon
Trimble
TRMB
+$4.73M
4
CZR icon
Caesars Entertainment
CZR
+$4.62M
5
PENN icon
PENN Entertainment
PENN
+$4.33M

Sector Composition

Rank Sector Weight
1 Technology 16.83%
2 Financials 10.85%
3 Consumer Discretionary 10.76%
4 Industrials 9.71%
5 Healthcare 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SQZ
3001
DELISTED
SQZ Biotechnologies Company
SQZ
$5K ﹤0.01%
373
– –
STSA
3002
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$5K ﹤0.01%
812
– –
LABP
3003
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$5K ﹤0.01%
+52
New +$6.79K
AGFS
3004
DELISTED
AgroFresh Solutions Inc
AGFS
$5K ﹤0.01%
2,627
– –
LOGC
3005
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$5K ﹤0.01%
670
– –
FNHC
3006
DELISTED
FedNat Holding Company Common Stock
FNHC
$5K ﹤0.01%
1,014
– –
CMPI
3007
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$5K ﹤0.01%
430
– –
GTT
3008
DELISTED
GTT Communications, Inc.
GTT
$5K ﹤0.01%
2,822
– –
AMLP icon
3009
Alerian MLP ETF
AMLP
$13.2B
$4K ﹤0.01%
158
-218
-58% -$6.37K
ASPS icon
3010
Altisource Portfolio Solutions
ASPS
$64.5M
$4K ﹤0.01%
51
– –
BH.A icon
3011
Biglari Holdings Class A
BH.A
$1.23B
$4K ﹤0.01%
6
– –
CBUS icon
3012
Cibus
CBUS
$144M
$4K ﹤0.01%
14
– –
DEO icon
3013
Diageo
DEO
$52.2B
$4K ﹤0.01%
27
– –
ELVN icon
3014
Enliven Therapeutics
ELVN
$4.24B
$4K ﹤0.01%
109
– –
IBB icon
3015
iShares Biotechnology ETF
IBB
$9.86B
$4K ﹤0.01%
30
– –
IBD icon
3016
Inspire Corporate Bond ETF
IBD
$489M
$4K ﹤0.01%
173
– –
LYRA
3017
DELISTED
LYRA THERAPEUTICS INC
LYRA
$4K ﹤0.01%
7
– –
MIRM icon
3018
Mirum Pharmaceuticals
MIRM
$6.04B
$4K ﹤0.01%
225
– –
NL icon
3019
NLI Holdings
NL
$329M
$4K ﹤0.01%
532
– –
NLY icon
3020
Annaly Capital Management
NLY
$17.4B
$4K ﹤0.01%
125
– –
PRTH icon
3021
Priority Technology Holdings
PRTH
$427M
$4K ﹤0.01%
578
– –
RMTI icon
3022
Rockwell Medical
RMTI
$29.6M
$4K ﹤0.01%
32
– –
SLNO
3023
DELISTED
Soleno Therapeutics
SLNO
$4K ﹤0.01%
197
– –
SMLV icon
3024
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$261M
$4K ﹤0.01%
40
– –
TPIF icon
3025
Timothy Plan International ETF
TPIF
$266M
$4K ﹤0.01%
179
– –
119 120
121
122 123

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return

Ameritas Investment Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Ameritas Investment Partners held 3,121 positions worth $2.62B, up 20% from $2.18B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners deployed $302M of net new capital in Q1 2021, opening 53 new positions and adding to 339 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 206,000 shares worth $75M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Enphase Energy, an estimated $5.93M trimmed.

  • Ameritas Investment Partners's largest Q1 2021 buy was Vanguard S&P 500 ETF: 206,000 shares worth $75M.
  • Ameritas Investment Partners added most to iShares Core US Aggregate Bond ETF in Q1 2021, an estimated $66.6M increase.
  • Ameritas Investment Partners's biggest Q1 2021 reduction was Enphase Energy, cutting an estimated $5.93M.
  • Ameritas Investment Partners fully exited Eaton Vance Corp. in Q1 2021, selling an estimated $2.14M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.62B portfolio in Q1 2021.
  • Ameritas Investment Partners opened 53 new positions and closed 28 in Q1 2021.
  • Ameritas Investment Partners's portfolio value rose 20% quarter-over-quarter to $2.62B.

Based on Ameritas Investment Partners's 13F filing for Q1 2021, filed 14 May 2021.